Prot# IMCL CP13-0604: A Phase 2 Randomized, Multicenter Study of IMC-A12 as a Single Agent or in Combination with Antiestrogens in Postmenopausal Women with Hormone Receptor-Positive Advanced or Metastatic Breast Cancer After Progression on Antiestrogen T